An international team of experts has provided the latest evidence-based recommendations for diagnosis, assessment, management, and treatment of neuronal ceroid lipofuscinosis type 2 (CLN2), a study reported.

The study, “Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients,” was published in the Orphanet Journal of Rare Diseases.

To read more, head to https://battendiseasenews.com/2021/05/27/new-guidelines-cln2-diagnosis-assessment-management